2. Anti-infection Apoptosis PI3K/Akt/mTOR Immunology/Inflammation
  3. Bacterial Apoptosis Fungal PI3K Akt TNF Receptor Interleukin Related
  4. Beauvericin

Beauvericin  (Synonyms: ビューベリシン)

製品番号: HY-N6739 純度: 99.97%
COA 取扱説明書 Technical Support

Beauvericin is a cyclohexapeptide Fusarium toxin with insecticidal, antibacterial, anticancer, antiviral and cytotoxic activities. Beauvericin causes cellular genotoxicity by producing DNA breaks, chromosomal aberrations and micronuclei, and inhibits the PI3K/AKT pathway to induce apoptosis, thereby inhibiting the growth of HCC. In addition, Beauvericin affects immune function by inhibiting lymphocyte proliferation and interfering with the differentiation process of human monocytes into macrophages.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

Beauvericin

Beauvericin 構造式

CAS 番号 : 26048-05-5

容量 価格（税別） 在庫状況 数量
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
 USD 328 在庫あり
Solution
10 mM * 1 mL in DMSO USD 328 在庫あり
Solid
5 mg $190 在庫あり
10 mg $304 在庫あり
25 mg $610 在庫あり
50 mg   お問い合わせ  
100 mg   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 0 publication(s) in Google Scholar

Other Forms of Beauvericin:

Beauvericin 関連抗体

Top Publications Citing Use of Products

PI3K アイソフォーム固有の製品をすべて表示:

すべてのアイソフォームを表示
PI3Kα PI3Kβ PI3Kγ PI3Kδ PI3KC2α PI3KC2β PI3KC2γ Vps34 PI3K PI3KC3 p120γ

Akt アイソフォーム固有の製品をすべて表示:

すべてのアイソフォームを表示
Akt Akt1 Akt2 Akt3

TNF Receptor アイソフォーム固有の製品をすべて表示:

すべてのアイソフォームを表示
TNFRSF1A/CD120a TNFRSF3/CD18 TNFRSF4 TNFRSF5/CD40 TNFRSF6/Fas/CD95 TNFRSF7/CD27 TNFRSF8/CD30 TNFRSF9/4-1BB/CD137 TNFRSF10B/DR5/CD262 TNFRSF12A/TWEAK TNFRSF16/NGF Receptor/CD271 TNFRSF18/GITR/CD357

Interleukin Related アイソフォーム固有の製品をすべて表示:

すべてのアイソフォームを表示
IL-1 IL-2 IL-3 IL-4 IL-5 IL-6 IL-8 IL-10 IL-12 IL-13 IL-15 IL-17 IL-23 IL-7 IL-33 IL-22 IL-18

  • 生物活性

  • 純度とドキュメンテーション

  • 参考文献

  • カスタマーレビュー

製品説明

Beauvericin is a cyclohexapeptide Fusarium toxin with insecticidal, antibacterial, anticancer, antiviral and cytotoxic activities. Beauvericin causes cellular genotoxicity by producing DNA breaks, chromosomal aberrations and micronuclei, and inhibits the PI3K/AKT pathway to induce apoptosis, thereby inhibiting the growth of HCC. In addition, Beauvericin affects immune function by inhibiting lymphocyte proliferation and interfering with the differentiation process of human monocytes into macrophages[1][2][3][4][5][6][7][8][9].

IC50 & Target

ACAT

 

Cellular Effect
Cell Line Type Value Description References
HepG2 IC50
1 μM
Compound: 12
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability after 48 hr by CCK-8 assay
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability after 48 hr by CCK-8 assay
[PMID: 36288556]
Huh-7 IC50
4.3 μM
Compound: 12
Antiproliferative activity against human Huh-7 cells assessed as reduction in cell viability after 48 hr by CCK-8 assay
Antiproliferative activity against human Huh-7 cells assessed as reduction in cell viability after 48 hr by CCK-8 assay
[PMID: 36288556]
体外実験

Beauvericin (0-20 μM; 12, 24 and 36 h) has a strong antiproliferative activity against H22 hepatoma cells and promotes apoptosis of H22 hepatoma cells[5].
Beauvericin (50 μM; 72 h) induces apoptosis in turkey peripheral mononuclear cells[6].
Beauvericin (0.3-100 µM) reversibly inhibits L-type voltage-dependent Ca2+ current (ICa,L) in NG108-15 neuronal cells in a concentration-dependent manner with an IC50 value of 4 µM[7].
Beauvericin has IC50 values ​​of 1.0 µM, 2.9 µM, and 2.5 µM for immature dendritic cells, mature dendritic cells, and macrophages, respectively[8].
Beauvericin (1.6 and 2.4 µM; 2 d) reduces CCR7 expression and increases IL-10 secretion in maturing dendritic cells[8].
Beauvericin is a potent inhibitor of CYP3A1/2 in rat liver microsomes (IC50=1.3 mM)[9].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Beauvericin 関連抗体

Cell Viability Assay[5]

Cell Line: H22 liver cancer cells
Concentration: 0, 1, 3, 5,10,15 and 20 µM
Incubation Time: 12、24 and 36 h
Result: Inhibited the growth of H22 cells in a dose-dependent manner.

Western Blot Analysis[5]

Cell Line: H22 liver cancer cells
Concentration: 0, 1, 3, 5,10,15 and 20 µM
Incubation Time: 12、24 and 36 h
Result: Upregulated the Bax/Bcl-2 ratio and the levels of cleaved caspase-9 and cleaved caspase-3, and downregulated the p-PI3K/PI3K ratio and p-AKT/AKT ratio.
体内実験

Beauvericin (5 mg/kg; i.p.; after the first dosing cycle, observe for two days and continue the second dosing cycle) reduces tumor volume and increases necrosis in allogeneic transplant model mice[3].
Beauvericin (3, 5, 7 mg/kg; i.p.; once a week for three weeks) can significantly inhibit the growth of H22 allogeneic transplant model mice and increase the levels of TNF-α and IL-2 in mice[5].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: BALB/c mice injected subcutaneously with mouse CT-26 colon cancer cells on the right side[3]
Dosage: 5 mg/kg
Administration: ntraperitoneal injection (i.p.)；The drug was administered on the third day after the injection of colon cancer cells and continued once a day for five days, then stopped for two days of observation, and continued on the tenth day after the injection of colon cancer cells, and continued once a day for four days.
Result: Reduced the average tumor volume by 52.8 % and the average tumor weight by 60 %.
Animal Model: Human cervical cancer KB-3-1 xenograft mouse model[3]
Dosage: 5 mg/kg
Administration: Intraperitoneal injection (i.p.)； The drug was administered once a day starting on the fifth day after cervical cancer injection for five days, followed by two days of observation. The drug was administered once a day starting on the twelfth day after cervical cancer cell injection for four days.
Result: Reduced the average tumor volume by 31.3 % and the average tumor weight by 31.2 %.
分子量

783.95

分子式

C45H57N3O9
CAS 番号
Appearance

Solid

Color

White to off-white

SMILES

CN([C@H](C(O[C@](C(N([C@H](C(O[C@@H]1C(C)C)=O)CC2=CC=CC=C2)C)=O)([H])C(C)C)=O)CC3=CC=CC=C3)C([C@H](OC([C@@H](N(C1=O)C)CC4=CC=CC=C4)=O)C(C)C)=O
Structure Classification
Initial Source

Fusarium proliferatum,F. semitectum, and F. subglutinans
輸送条件

Room temperature in continental US; may vary elsewhere.
保管条件
Powder -20°C 3 years
  4°C 2 years
In solvent -80°C 6 months
  -20°C 1 month
溶剤 & 溶解度
体外: 

DMSO : 100 mg/mL (127.56 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 1.2756 mL 6.3780 mL 12.7559 mL
5 mM 0.2551 mL 1.2756 mL 2.5512 mL
10 mM 0.1276 mL 0.6378 mL 1.2756 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます：C1V1 = C2V2

濃度 （開始）

C1

×
体積 （開始）

V1

=
濃度 （終了）

C2

×
体積 （終了）

V2

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
純度とドキュメンテーション

純度: 99.97%

COA (261 KB) HNMR (224 KB) RP-HPLC (266 KB) LCMS (89 KB)

取扱説明書 (2659 KB)
参考文献

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 1.2756 mL 6.3780 mL 12.7559 mL 31.8898 mL
5 mM 0.2551 mL 1.2756 mL 2.5512 mL 6.3780 mL
10 mM 0.1276 mL 0.6378 mL 1.2756 mL 3.1890 mL
15 mM 0.0850 mL 0.4252 mL 0.8504 mL 2.1260 mL
20 mM 0.0638 mL 0.3189 mL 0.6378 mL 1.5945 mL
25 mM 0.0510 mL 0.2551 mL 0.5102 mL 1.2756 mL
30 mM 0.0425 mL 0.2126 mL 0.4252 mL 1.0630 mL
40 mM 0.0319 mL 0.1594 mL 0.3189 mL 0.7972 mL
50 mM 0.0255 mL 0.1276 mL 0.2551 mL 0.6378 mL
60 mM 0.0213 mL 0.1063 mL 0.2126 mL 0.5315 mL
80 mM 0.0159 mL 0.0797 mL 0.1594 mL 0.3986 mL
100 mM 0.0128 mL 0.0638 mL 0.1276 mL 0.3189 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Beauvericin Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質量   濃度   体積   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます：C1V1 = C2V2

濃度 （開始） × 体積 （開始） = 濃度 （終了） × 体積 （終了）
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Beauvericin26048-05-5BacterialApoptosisFungalPI3KAktTNF ReceptorInterleukin RelatedPhosphoinositide 3-kinasePKBProtein kinase BTumor Necrosis Factor ReceptorTNFRILInhibitorinhibitorinhibit

最近チェックした製品:

オンラインお問い合わせ

Your information is safe with us. * Required Fields.

製品名

  

カスタマ需要量 *

お名前 *

 

タイトル

メールアドレス *

 

電話番号 *

デパートメント

 

組纖名 *

市区町村

都道府県

国或いは地域 *

      

必ず会社名を記載ください。個人への返信は行いません。

備考

バルクお問い合わせ

Inquiry Information

製品名:
Beauvericin
製品番号:
HY-N6739
数量:
MCE 日本正規代理店:

カスタマーレビュー

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

製品名

  

Lot #

お名前 *

 

メールアドレス *

電話番号 *

 

部門 *

組纖名 *

 

国或いは地域 *

備考

Request for HNMR Report

We have received your request and will respond to you as soon as possible.